Imidazo- and oxazolopyridines
    3.
    发明授权
    Imidazo- and oxazolopyridines 失效
    咪唑并恶唑并吡啶类

    公开(公告)号:US06306867B1

    公开(公告)日:2001-10-23

    申请号:US09678807

    申请日:2000-10-04

    IPC分类号: A61K31343

    CPC分类号: C07D471/04

    摘要: are useful for preventing or treating airway disorders, dermatoses, disorders based on excessive release of TNF and leukotrienes, disorders of the immune system and generalized inflammation in the gastrointestinal area.

    摘要翻译: 可用于预防或治疗气道疾病,皮肤病,基于TNF和白细胞三烯的过量释放的病症,免疫系统的紊乱和胃肠道区域的广泛性炎症。

    TETRAHYDROPYRIDOTHIOPHENES FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER
    7.
    发明申请
    TETRAHYDROPYRIDOTHIOPHENES FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER 审中-公开
    用于治疗增殖性疾病(如癌症)的四氢呋喃半胱氨酸

    公开(公告)号:US20100324038A1

    公开(公告)日:2010-12-23

    申请号:US12510362

    申请日:2009-07-28

    CPC分类号: C07D495/04

    摘要: The invention relates to compounds of formula I, wherein Ra is —C(O)OR1, in which R1 is 1-7C-alkyl, 3-7C-cycloalkyl, or 1-7C-alkyl substituted by one to four substituents independently selected from R2, Rb is -T-Q, in which T is 1-6C-alkylene or 3-7C-cycloalkylene, and either Q is optionally substituted by Rba and/or Rbb and/or Rbc, and is phenyl or naphthyl, or Q is optionally substituted by Rca and/or Rcb, and is Har, or Q is optionally substituted by Rda and/or Rdb, and is Het, or Q is optionally substituted by Rea and/or Reb, and is 3-7C-cycloalkyl, which are useful for the therapy of hyperproliferative diseases, in particular human cancer.

    摘要翻译: 本发明涉及式I化合物,其中R a为-C(O)OR 1,其中R 1为1-7C-烷基,3-7C-环烷基或被一至四个独立地选自 R2,Rb是-TQ,其中T是1-6C-亚烷基或3-7C-亚环烷基,并且Q任选地被Rba和/或Rbb和/或Rbc取代,并且是苯基或萘基,或Q是任选的 被Rca和/或Rcb取代,并且是Har,或Q任选被R da和/或R db取代,并且是Het,或Q任选地被Rea和/或Reb取代,并且是3-7C-环烷基,它们是 可用于治疗过度增殖性疾病,特别是人类癌症。